Investor · 3 deals
Every published round HEST A took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Heidi Health | Series A | 26 Aug 2026 | $16.6m | Participant | Dynamic Business, Dealroom (22 Sep 2026), Forbes Australia, Dealroom (27 Aug 2026), AFR Technology, Blackbird Ventures portfolio | |
| Gilmour Space | Series D+ | 20 Jan 2026 | $217m | Participant | Business News Australia, Startup Daily, SmartCompany (28 Apr 2026), SmartCompany (23 Jan 2026), Beaten Zone Venture Partners, SmartCompany (20 Jan 2026), Dealroom, Main Sequence Ventures portfolio | |
| Heidi Health | Series A | 25 Oct 2023 | $10m | Participant | SmartCompany (6 May 2026), Startup Daily (10 Oct 2025), SmartCompany (10 Oct 2025), Startup Daily (6 Oct 2025), SmartCompany (6 Oct 2025), SmartCompany (28 Aug 2025), SmartCompany (7 Mar 2025), Startup Daily (4 Mar 2025), SmartCompany (19 Dec 2023), SmartCompany (27 Oct 2023), SmartCompany (27 Oct 2023), Startup Daily (26 Oct 2023), SmartCompany (26 Oct 2023), TechCrunch Australia |
Companies HEST A has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Heidi Health | Australian HealthTech company | 25 Oct 2023, Series A | 2 | 0 |
| Gilmour Space | Queensland rocket builder and launchpad scaleup | 20 Jan 2026, Series D+ | 1 | 0 |
This is a stake in the fund itself, money that the fund's manager invests, not a stake in the fund manager.
Companies HEST A has backed that another company then bought. An exit for the holding, not a deal HEST A did.
Stories naming HEST A. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Novartis is acquiring London biotech Myricx Bio for US$1.1 billion upfront plus milestone payments, handing Melbourne venture firm Brandon Capital a record return on the startup it seeded in 2019.
Roundup of four ANZ raises: a Queensland rocket company's nine-figure Series E, a New Zealand legal-AI firm's Series B, a seed round for AI code-security, and a Melbourne construction-software raise.
Rocket firm Gilmour Space raised a $217 million Series E co-led by the National Reconstruction Fund and Hostplus, reaching a billion-dollar valuation; earlier Series B, C and D raises are recapped.
RecordPoint has bought Redactive AI, a Melbourne data security startup founded by former Atlassian staff, for an undisclosed sum two years after its founding; Felicis and Blackbird co-led its 2024 seed round.
Australia's NRFC has injected $150m into Brandon Capital's sixth life-science vehicle, lifting it to a $439m close; past NRFC cheques to local deep-tech firms are also recapped.
Heidi Health, whose AI tool drafts doctors' clinical notes, has added $26.8 million to its Series A in a round led by Headline, with Local Globe and Anthology also taking part.
Also SmartCompany·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily